Trial intelligence / Profile preview

Bimatoprost Formulation A for Eyelash Hypotrichosis

NCT01698554Phase 3Completed

Sponsor
Allergan
Start
Nov 2012
Primary completion
Feb 2014
Modality
Orthosteric Ligands
Countries
4
01

Overview

A Phase 3 trial of bimatoprost in eyelash hypotrichosis, sponsored by Allergan. Started Nov 2012; status: completed.

02

Drugs

bimatoprost
03

Conditions

eyelash hypotrichosis

Beyond the preview

Go deeper on NCT01698554.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01698554.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call